SSR128129E
Product Specifications
UNSPSC Description
SSR128129E is an orally available and allosteric FGFR inhibitor with an IC50 of 1.9 μM for FGFR1.
Target Antigen
FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/SSR128129E.html
Solubility
DMSO : ≥ 54 mg/mL
Smiles
O=C(O[Na])C1=CC(C(C2=C(C)C(OC)=C3C=CC=CN23)=O)=CC=C1N
Molecular Weight
346.31
References & Citations
[1]Bono F, et al. Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties. Cancer Cell. 2013 Apr 15;23(4):477-88.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-15599/SSR128129E-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-15599/SSR128129E-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
848318-25-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC220659L4 10 µg
alpha 2b Adrenergic Receptor (ADRA2B) (NM_000682) Human Tagged Lenti ORF Clone
Ask
View Details 
